The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors
Inflammasome activation is a pivotal step for the maturation of IL-1β, which is involved in the development and progression of gastric cancer (GC). Endocannabinoids, such as anandamide (AEA), are emerging as new anticancer therapeutic agents; however, their effects on inflammasome components and und...
Saved in:
Main Authors: | Sahar Sadat Sedeighzadeh, Hamid Galehdari, Mohammad Reza Tabandeh, Mehdi Shamsara, Ali Roohbakhsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/6698049 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
by: Natalia Malek, et al.
Published: (2015-01-01) -
Phytoestrogens Enhance the Vascular Actions of the Endocannabinoid Anandamide in Mesenteric Beds of Female Rats
by: Roxana N. Peroni, et al.
Published: (2012-01-01) -
Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice
by: Carolina Aguirre, et al.
Published: (2017-01-01) -
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
by: Joseph Bouskila, et al.
Published: (2016-01-01) -
Antimicrobial, Conductive, and Mechanical Properties of AgCB/PBS Composite System
by: Chatchai Veranitisagul, et al.
Published: (2019-01-01)